Suppr超能文献

关于在表面固定有终点肝素的情况下凝血抑制的机制。

On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.

作者信息

Elgue G, Blombäck M, Olsson P, Riesenfeld J

机构信息

Department of Experimental Surgery, Karolinska Hospital, Stockholm, Sweden.

出版信息

Thromb Haemost. 1993 Aug 2;70(2):289-93.

PMID:8236137
Abstract

A well established technique to improve blood compatibility of artificial materials for use in the circulation is to coat the surface with heparin. The present report describes the antithrombin mediated inhibition of thrombin and factor Xa by surfaces modified with end point immobilized heparin. The reaction was followed by conventional chromogenic substrate based enzyme assays as well as by immunological measurement of the enzyme inhibitor (thrombin-antithrombin) complex formation. Both enzymes were rapidly inactivated by heparin surfaces after selective presaturation with antithrombin on the immobilized high affinity heparin molecules. The thrombin inhibitory capacity was enhanced when both high and low affinity heparin were preadsorbed with inhibitor. The main part of the thrombin-antithrombin complex formed remained bound to the surface, however, without functionally blocking the activity of the high affinity sequence of the immobilized heparin. Aliquots of recalcified plasma were slowly rotated in loops of heparinized tubing to investigate whether the main thromboresistant function of the surface was exerted at the level of thrombin or by inactivation of preceding enzymes. After 1 h no visible clotting occurred and only trace amounts of thrombin (0.07 IU/ml), measured as thrombin-antithrombin complexes, had been formed. In non-heparinized loops and in the test tube plasma clotted after 20 min. The thrombin generation when clotting occurred was in the order of 10 IU/ml. It is concluded that the immobilized heparin mediates inhibition of the coagulation cascade prior to prothrombin activation.

摘要

一种成熟的改善用于循环系统的人工材料血液相容性的技术是用肝素包被材料表面。本报告描述了通过终点固定化肝素修饰的表面,抗凝血酶介导的对凝血酶和因子Xa的抑制作用。通过传统的基于显色底物的酶测定以及酶抑制剂(凝血酶 - 抗凝血酶)复合物形成的免疫测定来跟踪反应。在用抗凝血酶选择性预饱和固定化的高亲和力肝素分子后,两种酶都被肝素表面迅速灭活。当高亲和力和低亲和力肝素都预先用抑制剂吸附时,凝血酶抑制能力增强。形成的凝血酶 - 抗凝血酶复合物的主要部分仍与表面结合,然而,并未在功能上阻断固定化肝素高亲和力序列的活性。将重新钙化的血浆等分试样在肝素化管的环中缓慢旋转,以研究表面的主要抗血栓形成功能是在凝血酶水平发挥作用还是通过使先前的酶失活来实现。1小时后未出现可见的凝血,并且仅形成了痕量的凝血酶(0.07 IU/ml),以凝血酶 - 抗凝血酶复合物形式测量。在未肝素化的环中以及在试管中,血浆在20分钟后凝结。凝血发生时的凝血酶生成量约为10 IU/ml。结论是固定化肝素在凝血酶原激活之前介导凝血级联反应的抑制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验